From: Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients
Supracor + Supracor | Supracor + Standard LASIK | Supracor + No Treatment | P Value | |
---|---|---|---|---|
Patients | 11 | 18 | 29 | n/a |
Male | 3 | 10 | 12 | n/a |
Female | 8 | 8 | 17 | |
Mean Age (Years) | 53.18 ± 3.20 | 50.56 ± 4.38 | 50.83 ± 4.68 | 0.70 |
UDVA | 0.63 ± 0.18 | 0.43 ± 0.21 | 0.05 ± 0.06 | 0.00 |
UIVA | 0.40 ± 0.00 | 0.40 ± 0.00 | 0.30 ± 0.12 | 0.16 |
UNVA | 0.70 ± 0.00 | 0.68 ± 0.06 | 0.53 ± 0.22 | 0.16 |
Sphere (D) | 1.98 ± 0.39 | 1.97 ± 0.69 | 1.02 ± 0.52 | 0.00 |
Cylinder (D) | −0.39 ± 0.26 | −0.33 ± 0.33 | −0.47 ± 0.49 | 0.46 |
Spherical Equivalent (SE) (D) | 1.78 ± 0.34 | 1.81 ± 0.72 | 0.78 ± 0.48 | 0.00 |